Aravis Life Sciences is a private equity general partner firm headquartered in Zurich, Switzerland.
VC-backed Swiss biotechnology compan Symetis is planning a Zurich IPO, a strong sign for the Swiss healthcare sector.
Aravis Venture and Proquest Investments led a $6.6m Series B round for Telormedix, a Swiss bio-pharmaceutical company.
Read more news concerning Aravis Life Sciences
A sampling of Aravis Life Sciences portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?